drugset / Trial / NCT00855010
Pioglitazone on Pancreatic Steatosis and Bone Health
Completed
42 enrolled
University of Texas Southwestern Medical Center
National Institutes of Health (NIH) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Randomized, double blind, placebo controlled trial evaluating the effect of pioglitazone on pancreatic fat content and bone turnover markers.
Timeline
- Start
- 2009-02
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pioglitazone | Small molecule | 45 mg | — |